Screener
Pacira BioSciences, Inc. PCRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s asset turnover?
- Pacira BioSciences, Inc. (PCRX) reported asset turnover of 0.5× in Q1 2026.
- How has Pacira BioSciences, Inc.'s asset turnover changed year-over-year?
- Pacira BioSciences, Inc.'s asset turnover increased by 18.6% year-over-year, from 0.4× to 0.5×.
- What is the long-term trend for Pacira BioSciences, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s asset turnover has grown at a 4.8% compound annual growth rate (CAGR), from 0.4× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Pacira BioSciences, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude